Evidence map›Paper›PMID 29976697›Full record

ArticleJournal of nuclear medicine : official publication, Society of Nuclear Medicine2019

Stefan A Koerber, Leon Will, Clemens Kratochwil, Matthias F Haefner, Henrik Rathke, Christophe Kremer, Jonas Merkle, Klaus Herfarth, Klaus Kopka, Peter L Choyke and 4 more

Open access · bronzeAbstract read
In one paragraph

Article in Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
27citing papers in PubMed, 2 pooled it
7.1field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

27 citing papers in PubMed, 2 syntheses or guidelines pooled it, 53 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. A Prospective Study onJournal of nuclear medicine : official publication, Society of Nuclear Medicine · 2019
    Trial
  4. Article
  5. Controversies in the use of next-generation imaging for evaluation and treatment decision-making in patients with prostate cancer after biochemical recurrence: views from a Spanish expert panel.Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico · 2025
    Review
  6. Review
  7. A comparative study ofBMC medical imaging · 2024
    Article
  8. Impact ofJournal of nuclear medicine : official publication, Society of Nuclear Medicine · 2023
    Article
  9. Review
  10. Article
  11. Management impact ofEuropean journal of nuclear medicine and molecular imaging · 2021
    Article
  12. Article
  13. High detection rate in [Annals of nuclear medicine · 2021
    Article
  14. Article
  15. Clinical outcome of PSMA-guided radiotherapy for patients with oligorecurrent prostate cancer.European journal of nuclear medicine and molecular imaging · 2021
    Article
  16. Article
  17. Review
  18. Automated [EJNMMI radiopharmacy and chemistry · 2020
    Article
  19. Impact ofEuropean journal of nuclear medicine and molecular imaging · 2020
    Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 5 institutions in 2 countries.

Stefan A KoerberUniversity Hospital Heidelberg, Heidelberg, Germany.
Leon WillUniversity Hospital Heidelberg, Heidelberg, Germany.
Clemens KratochwilUniversity Hospital Heidelberg, Heidelberg, Germany.
Matthias F HaefnerUniversity Hospital Heidelberg, Heidelberg, Germany.
Henrik RathkeUniversity Hospital Heidelberg, Heidelberg, Germany.
Christophe KremerUniversity Hospital Heidelberg, Heidelberg, Germany.
Jonas MerkleUniversity Hospital Heidelberg, Heidelberg, Germany.
Klaus HerfarthUniversity Hospital Heidelberg, Heidelberg, Germany.
Klaus KopkaGerman Cancer Research Center (DKFZ), Heidelberg, Germany.
Peter L ChoykeNational Cancer Institute, National Institutes of Health, Bethesda, MD, USA.
Tim Holland-LetzGerman Cancer Research Center (DKFZ), Heidelberg, Germany.
Uwe HaberkornUniversity Hospital Heidelberg, Heidelberg, Germany.
Juergen DebusUniversity Hospital Heidelberg, Germany.
Frederik L GieselUniversity Hospital Heidelberg, Germany.
Heidelberg University · DEGerman Cancer Research Center · DEUniversity Hospital Heidelberg · DECenter for Cancer Research · USHeidelberger Institut für Radioonkologie · DE

Funding

Prostate Cancer ImagingZIABC010655 · NCI · DIVISION OF BASIC SCIENCES - NCI · PI CHOYKE, PETER L · 2009 to 2025
$49.2M
6 · The paper itself

Abstract

The present study analyzed the impact of Gallium-68 (

Indexed as

Oncology: GUPET/CTprostate cancerPSMARadiation Therapy Planningradiotherapystaging

Identifiers

PMID29976697
PMCPMC8833857
OpenAlexW2831039135

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.